Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people.

Todd A, Jansen J, Colvin J, McLachlan AJ.

BMC Geriatr. 2018 Nov 29;18(1):295. doi: 10.1186/s12877-018-0978-x.

2.

Editorial: Drug delivery in older people - unique challenges and important opportunities.

McLachlan AJ, Cogger VC.

Adv Drug Deliv Rev. 2018 Oct;135:1-2. doi: 10.1016/j.addr.2018.11.002. No abstract available.

PMID:
30466511
3.

Non-prescription sales of antimicrobial agents at community pharmacies in developing countries: a systematic review.

Sakeena MHF, Bennett AA, McLachlan AJ.

Int J Antimicrob Agents. 2018 Oct 9. pii: S0924-8579(18)30281-4. doi: 10.1016/j.ijantimicag.2018.09.022. [Epub ahead of print] Review.

PMID:
30312654
4.

A Strategy to Refine the Phenotyping Approach and Its Implementation to Predict Drug Clearance: A Physiologically Based Pharmacokinetic Simulation Study.

Adiwidjaja J, Boddy AV, McLachlan AJ.

CPT Pharmacometrics Syst Pharmacol. 2018 Sep 27. doi: 10.1002/psp4.12355. [Epub ahead of print]

5.

Evaluation of the impact of pharmacist-led medication reconciliation intervention: a single centre pre-post study from Ethiopia.

Mekonnen AB, McLachlan AJ, Brien JE, Mekonnen D, Abay Z.

Int J Clin Pharm. 2018 Oct;40(5):1209-1216. doi: 10.1007/s11096-018-0722-9. Epub 2018 Aug 28.

PMID:
30155773
6.

Invasive Candidiasis in the Elderly: Considerations for Drug Therapy.

Dekkers BGJ, Veringa A, Marriott DJE, Boonstra JM, van der Elst KCM, Doukas FF, McLachlan AJ, Alffenaar JC.

Drugs Aging. 2018 Sep;35(9):781-789. doi: 10.1007/s40266-018-0576-9. Review.

7.

Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis.

Enke O, New HA, New CH, Mathieson S, McLachlan AJ, Latimer J, Maher CG, Lin CC.

CMAJ. 2018 Jul 3;190(26):E786-E793. doi: 10.1503/cmaj.171333.

8.

Patterns of platinum drug use in an acute care setting: a retrospective study.

Armstrong-Gordon E, Gnjidic D, McLachlan AJ, Hosseini B, Grant A, Beale PJ, Wheate NJ.

J Cancer Res Clin Oncol. 2018 Aug;144(8):1561-1568. doi: 10.1007/s00432-018-2669-6. Epub 2018 May 22.

PMID:
29789926
9.

Enhancing pharmacists' role in developing countries to overcome the challenge of antimicrobial resistance: a narrative review.

Sakeena MHF, Bennett AA, McLachlan AJ.

Antimicrob Resist Infect Control. 2018 May 2;7:63. doi: 10.1186/s13756-018-0351-z. eCollection 2018. Review.

10.

Exploring current and potential roles of Australian community pharmacists in gout management: a qualitative study.

Counsell AB, Nguyen AD, Baysari MT, Kannangara DRW, McLachlan AJ, Day RO.

BMC Fam Pract. 2018 May 9;19(1):54. doi: 10.1186/s12875-018-0744-3.

11.

Investigating knowledge regarding antibiotics and antimicrobial resistance among pharmacy students in Sri Lankan universities.

Sakeena MHF, Bennett AA, Jamshed S, Mohamed F, Herath DR, Gawarammana I, McLachlan AJ.

BMC Infect Dis. 2018 May 8;18(1):209. doi: 10.1186/s12879-018-3107-8.

12.

A Scoping Review of Peer-led Education in Patient Safety Training.

Walpola RL, McLachlan AJ, Chen TF.

Am J Pharm Educ. 2018 Mar;82(2):6110. doi: 10.5688/ajpe6110. Review.

13.

Which supplements can I recommend to my osteoarthritis patients?

Liu X, Eyles J, McLachlan AJ, Mobasheri A.

Rheumatology (Oxford). 2018 May 1;57(suppl_4):iv75-iv87. doi: 10.1093/rheumatology/key005. Review.

PMID:
29506080
14.

Correction: Management of vertebral compression fracture in general practice: BEACH program.

Megale RZ, Pollack A, Britt H, Latimer J, Naganathan V, McLachlan AJ, Ferreira ML.

PLoS One. 2018 Feb 22;13(2):e0193531. doi: 10.1371/journal.pone.0193531. eCollection 2018.

15.

Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.

Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ.

J Pharm Pharmacol. 2019 Jan;71(1):129-138. doi: 10.1111/jphp.12858. Epub 2018 Feb 7. Review.

PMID:
29411879
16.

Barriers and facilitators to hospital pharmacists' engagement in medication safety activities: a qualitative study using the theoretical domains framework.

Mekonnen AB, McLachlan AJ, Brien JE, Mekonnen D, Abay Z.

J Pharm Policy Pract. 2018 Jan 23;11:2. doi: 10.1186/s40545-018-0129-y. eCollection 2018.

17.

Prevalence of Potentially Inappropriate Medication Use in Older Inpatients with and without Cognitive Impairment: A Systematic Review.

Redston MR, Hilmer SN, McLachlan AJ, Clough AJ, Gnjidic D.

J Alzheimers Dis. 2018;61(4):1639-1652. doi: 10.3233/JAD-170842.

PMID:
29278890
18.

Efficacy and Safety of Oral and Transdermal Opioid Analgesics for Musculoskeletal Pain in Older Adults: A Systematic Review of Randomized, Placebo-Controlled Trials.

Megale RZ, Deveza LA, Blyth FM, Naganathan V, Ferreira PH, McLachlan AJ, Ferreira ML.

J Pain. 2018 May;19(5):475.e1-475.e24. doi: 10.1016/j.jpain.2017.12.001. Epub 2017 Dec 11. Review.

PMID:
29241834
19.

What do Australian consumers, pharmacists and prescribers think about documenting indications on prescriptions and dispensed medicines labels?: A qualitative study.

Garada M, McLachlan AJ, Schiff GD, Lehnbom EC.

BMC Health Serv Res. 2017 Nov 15;17(1):734. doi: 10.1186/s12913-017-2704-3.

20.

Adverse Drug Events and Medication Errors in African Hospitals: A Systematic Review.

Mekonnen AB, Alhawassi TM, McLachlan AJ, Brien JE.

Drugs Real World Outcomes. 2018 Mar;5(1):1-24. doi: 10.1007/s40801-017-0125-6. Review.

21.

Exploring the enablers and barriers to implementing the Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) criteria in Australia: a qualitative study.

Page AT, Clifford RM, Potter K, Seubert L, McLachlan AJ, Hill X, King S, Clark V, Ryan C, Parekh N, Etherton-Beer CD.

BMJ Open. 2017 Aug 23;7(8):e017906. doi: 10.1136/bmjopen-2017-017906.

22.

Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions.

Adiwidjaja J, McLachlan AJ, Boddy AV.

Expert Opin Drug Metab Toxicol. 2017 Sep;13(9):953-972. doi: 10.1080/17425255.2017.1360279. Epub 2017 Aug 10. Review.

PMID:
28776444
23.

Abdominal functional electrical stimulation to improve respiratory function after spinal cord injury: a systematic review and meta-analysis.

McCaughey EJ, Borotkanics RJ, Gollee H, Folz RJ, McLachlan AJ.

Spinal Cord. 2017 Aug;55(8):798. doi: 10.1038/sc.2017.2.

PMID:
28775367
24.

Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure.

Brett J, Karanges EA, Daniels B, Buckley NA, Schneider C, Nassir A, Zoega H, McLachlan AJ, Pearson SA.

Aust N Z J Psychiatry. 2017 Oct;51(10):990-999. doi: 10.1177/0004867417721018. Epub 2017 Jul 31.

PMID:
28758432
25.

Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study.

Brett J, Daniels B, Karanges EA, Buckley NA, Schneider C, Nassir A, McLachlan AJ, Pearson SA.

Br J Clin Pharmacol. 2017 Nov;83(11):2581-2588. doi: 10.1111/bcp.13369. Epub 2017 Aug 16.

26.

Worsening trends in analgesics recommended for spinal pain in primary care.

Mathieson S, Valenti L, Maher CG, Britt H, Li Q, McLachlan AJ, Lin CC.

Eur Spine J. 2018 May;27(5):1136-1145. doi: 10.1007/s00586-017-5178-4. Epub 2017 Jun 21.

PMID:
28639074
27.

Comparison of effect sizes between enriched and nonenriched trials of analgesics for chronic musculoskeletal pain: a systematic review.

Yamato TP, Maher CG, Saragiotto BT, Shaheed CA, Moseley AM, Lin CC, Koes B, McLachlan AJ.

Br J Clin Pharmacol. 2017 Nov;83(11):2347-2355. doi: 10.1111/bcp.13350. Epub 2017 Aug 11. Review.

28.

Life-threatening drug interactions: what the physician needs to know.

Day RO, Snowden L, McLachlan AJ.

Intern Med J. 2017 May;47(5):501-512. doi: 10.1111/imj.13404. Review.

PMID:
28503886
29.

Management of vertebral compression fracture in general practice: BEACH program.

Megale RZ, Pollack A, Britt H, Latimer J, Naganathan V, McLachlan AJ, Ferreira ML.

PLoS One. 2017 May 4;12(5):e0176351. doi: 10.1371/journal.pone.0176351. eCollection 2017. Erratum in: PLoS One. 2018 Feb 22;13(2):e0193531.

30.

Pharmacist-led admission medication reconciliation before and after the implementation of an electronic medication management system.

Sardaneh AA, Burke R, Ritchie A, McLachlan AJ, Lehnbom EC.

Int J Med Inform. 2017 May;101:41-49. doi: 10.1016/j.ijmedinf.2017.02.001. Epub 2017 Feb 8.

PMID:
28347446
31.

Trial of Pregabalin for Acute and Chronic Sciatica.

Mathieson S, Maher CG, McLachlan AJ, Latimer J, Koes BW, Hancock MJ, Harris I, Day RO, Billot L, Pik J, Jan S, Lin CC.

N Engl J Med. 2017 Mar 23;376(12):1111-1120. doi: 10.1056/NEJMoa1614292.

32.

"I have nine specialists. They need to swap notes!" Australian patients' perspectives of medication-related problems following discharge from hospital.

Eassey D, McLachlan AJ, Brien JA, Krass I, Smith L.

Health Expect. 2017 Oct;20(5):1114-1120. doi: 10.1111/hex.12556. Epub 2017 Mar 17.

33.

Evaluating the Effectiveness of an Educational Intervention to Improve the Patient Safety Attitudes of Intern Pharmacists.

Walpola RL, Fois RA, McLachlan AJ, Chen TF.

Am J Pharm Educ. 2017 Feb 25;81(1):5. doi: 10.5688/ajpe8115.

34.

Authors' reply to the comment by Durg.

Abdel Shaheed C, McLachlan AJ, Maher CG.

Eur J Pain. 2017 Feb;21(2):400. doi: 10.1002/ejp.1005. No abstract available.

PMID:
28068005
35.

Medication reconciliation as a medication safety initiative in Ethiopia: a study protocol.

Mekonnen AB, McLachlan AJ, Brien JE, Mekonnen D, Abay Z.

BMJ Open. 2016 Nov 24;6(11):e012322. doi: 10.1136/bmjopen-2016-012322.

36.

Single-dose pharmacokinetics and cardiovascular effects of oral pimobendan in healthy cats.

Yata M, McLachlan AJ, Foster DJ, Hanzlicek AS, Beijerink NJ.

J Vet Cardiol. 2016 Dec;18(4):310-325. doi: 10.1016/j.jvc.2016.07.001. Epub 2016 Sep 6.

PMID:
27613648
37.

The economic burden of guideline-recommended first line care for acute low back pain.

Lin CC, Li Q, Williams CM, Maher CG, Day RO, Hancock MJ, Latimer J, Mclachlan AJ, Jan S.

Eur Spine J. 2018 Jan;27(1):109-116. doi: 10.1007/s00586-016-4781-0. Epub 2016 Sep 21.

PMID:
27652679
38.

Abdominal functional electrical stimulation to improve respiratory function after spinal cord injury: a systematic review and meta-analysis.

McCaughey EJ, Borotkanics RJ, Gollee H, Folz RJ, McLachlan AJ.

Spinal Cord. 2016 Sep;54(9):754. doi: 10.1038/sc.2016.70. No abstract available.

PMID:
27589218
39.

OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain. Trial protocol.

Lin CW, McLachlan AJ, Latimer J, Day RO, Billot L, Koes BW, Maher CG.

BMJ Open. 2016 Aug 24;6(8):e011278. doi: 10.1136/bmjopen-2016-011278.

40.

Impact of electronic medication reconciliation interventions on medication discrepancies at hospital transitions: a systematic review and meta-analysis.

Mekonnen AB, Abebe TB, McLachlan AJ, Brien JA.

BMC Med Inform Decis Mak. 2016 Aug 22;16:112. doi: 10.1186/s12911-016-0353-9. Review.

41.

Medication appropriateness tool for co-morbid health conditions in dementia: consensus recommendations from a multidisciplinary expert panel.

Page AT, Potter K, Clifford R, McLachlan AJ, Etherton-Beer C.

Intern Med J. 2016 Oct;46(10):1189-1197. doi: 10.1111/imj.13215.

42.

Efficacy and tolerability of muscle relaxants for low back pain: Systematic review and meta-analysis.

Abdel Shaheed C, Maher CG, Williams KA, McLachlan AJ.

Eur J Pain. 2017 Feb;21(2):228-237. doi: 10.1002/ejp.907. Epub 2016 Jun 22. Review.

PMID:
27329976
43.

Too much medicine in older people? Deprescribing through shared decision making.

Jansen J, Naganathan V, Carter SM, McLachlan AJ, Nickel B, Irwig L, Bonner C, Doust J, Colvin J, Heaney A, Turner R, McCaffery K.

BMJ. 2016 Jun 3;353:i2893. doi: 10.1136/bmj.i2893. No abstract available.

PMID:
27260319
44.

Efficacy, Tolerability, and Dose-Dependent Effects of Opioid Analgesics for Low Back Pain: A Systematic Review and Meta-analysis.

Abdel Shaheed C, Maher CG, Williams KA, Day R, McLachlan AJ.

JAMA Intern Med. 2016 Jul 1;176(7):958-68. doi: 10.1001/jamainternmed.2016.1251. Review.

PMID:
27213267
45.

Timing of Administration: For Commonly-Prescribed Medicines in Australia.

Kaur G, Phillips CL, Wong K, McLachlan AJ, Saini B.

Pharmaceutics. 2016 Apr 15;8(2). pii: E13. doi: 10.3390/pharmaceutics8020013. Review.

46.

Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand.

Barnes J, McLachlan AJ, Sherwin CM, Enioutina EY.

Expert Rev Clin Pharmacol. 2016 Jul;9(7):905-15. doi: 10.1586/17512433.2016.1171712. Epub 2016 Apr 12. Review.

PMID:
27070431
47.

Abdominal functional electrical stimulation to improve respiratory function after spinal cord injury: a systematic review and meta-analysis.

McCaughey EJ, Borotkanics RJ, Gollee H, Folz RJ, McLachlan AJ.

Spinal Cord. 2016 Sep;54(9):628-39. doi: 10.1038/sc.2016.31. Epub 2016 Apr 12. Review. Erratum in: Spinal Cord. 2017 Aug;55(8):798. Spinal Cord. 2016 Sep;54(9):754.

PMID:
27067658
48.

Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis.

Mekonnen AB, McLachlan AJ, Brien JA.

J Clin Pharm Ther. 2016 Apr;41(2):128-44. doi: 10.1111/jcpt.12364. Epub 2016 Feb 23. Review.

PMID:
26913812
49.

Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis.

Mekonnen AB, McLachlan AJ, Brien JA.

BMJ Open. 2016 Feb 23;6(2):e010003. doi: 10.1136/bmjopen-2015-010003. Review.

50.

High melphalan exposure is associated with improved overall survival in myeloma patients receiving high dose melphalan and autologous transplantation.

Nath CE, Trotman J, Tiley C, Presgrave P, Joshua D, Kerridge I, Kwan YL, Gurney H, McLachlan AJ, Earl JW, Nivison-Smith I, Zeng L, Shaw PJ.

Br J Clin Pharmacol. 2016 Jul;82(1):149-59. doi: 10.1111/bcp.12906. Epub 2016 Apr 27.

Supplemental Content

Loading ...
Support Center